BTCRC-HEM15-027
Phase I Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027
Status: Closed to Accrual
Learn more:
- clinicaltrials.gov: #NCT03681561
- See Study Locations on Big Ten CRC Website
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter